We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Coughlin Stoia Attys Seek $18M In Celexa Deal Fees

Law360 (February 2, 2009, 12:00 AM EST) -- Lead counsel for the plaintiffs in a securities class action alleging that Forest Laboratories Inc. provided misleading information about the safety of its blockbuster antidepressants Celexa and Lexapro have asked for...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

New York Southern

Nature of Suit

Securities/Commodities

Judge

Subscribers Only

Date Filed

March 11, 2005

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.